The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / BFA_2017_HRBFIE-FEL_V01_M / variable [F9]
impact_evaluation

Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey

Burkina Faso, 2017
Get Microdata
Reference ID
BFA_2017_HRBFIE-FEL_v01_M
DOI
https://doi.org/10.48529/01gp-gm52
Producer(s)
Manuela de Allegri, Herve Hien, Paul Jacob Robyn
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
Aug 27, 2019
Last modified
Oct 01, 2019
Page views
195047
Downloads
2588
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Related datasets
  • Data files
  • f1_jul19
  • f1p_jul19
  • f1u_jul19
  • f2_jul19
  • f3_jul19
  • f4_jul19
  • f5_jul19
  • f6_jul19
  • f7_jul19

F7_218_M (f7_218_5)

Data file: f7_jul19

Overview

Valid: 189
Invalid: 0
Type: Discrete
Start: 485
End: 509
Width: 25
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
0 11
5.8%
00 20
10.6%
2 1
0.5%
3 4
2.1%
4 1
0.5%
8:53:51 1
0.5%
99 1
0.5%
ACT 1
0.5%
ASL 1
0.5%
ASL 900 1
0.5%
ASL 900mg 1
0.5%
ASL+HPV 1
0.5%
ASL900 1
0.5%
ASLI njectable 1
0.5%
ASl 1
0.5%
Albendazol cp 1
0.5%
Albendazole 1
0.5%
Amoxicyline gel 1
0.5%
Ampi 1g 1
0.5%
Betadine 1
0.5%
Carbotoux 1
0.5%
Ceftri inj 1g 1
0.5%
Expectoral 1
0.5%
FAF 1
0.5%
Gant 2
1.1%
Guant-Seringue 1
0.5%
HPR 1
0.5%
HPV inj 1
0.5%
Hydrocortisone 1
0.5%
Ibuprofene 1
0.5%
Ibuprofène 1
0.5%
Ibuprofène, betadine 1
0.5%
Intranule,perfuseur 1
0.5%
Lumarter 1
0.5%
METRO INJ 1
0.5%
MULTI VITAMINE 1
0.5%
Mebendazol 1
0.5%
Metronidazole,gant 1
0.5%
PARACETAMOL 1
0.5%
PARACETAMOL 500 MG 1
0.5%
PHENOXYMETHILPENICINIL 1
0.5%
POVIDONE IODINE 1
0.5%
Para 500mg 1
0.5%
Paracetamol 2
1.1%
Paracetamol comp 1
0.5%
Perfalgan 1
0.5%
Perfalgan inj 1
0.5%
Phliso 1
0.5%
Prunex pomade 1
0.5%
Ringer 1
0.5%
SERINGUE. GANT D'EXAMEN 1
0.5%
Seringue 5cc 1
0.5%
Sparadrap 1
0.5%
TIG 1
0.5%
VAT 2
1.1%
acide ascorbique 1
0.5%
albendazole cp 400mg 1
0.5%
albendazole sirop 1
0.5%
amoxi 1
0.5%
amoxi. ibuprofen 1
0.5%
amoxiciline 1
0.5%
amoxicilline 4
2.1%
amoxicilline comp 1
0.5%
ampi 1g 06 flacons 1
0.5%
ampi injec seringue 5cc 1
0.5%
ampi inject 1
0.5%
asl 3
1.6%
aspirine 1
0.5%
bande 1
0.5%
bande crepe 1
0.5%
bande nylex 1
0.5%
bbp+xylo+eppi 1
0.5%
betadine 3
1.6%
carbotou 5% 1
0.5%
carbotoux sirop 1
0.5%
ceftri 1g 1
0.5%
chlor,para,amoxi,quinine 1
0.5%
cimetidine cp 1
0.5%
ciptin forte 1
0.5%
compress 1
0.5%
compresse 1
0.5%
cotri cp 1
0.5%
diasepam et metopimenzine 1
0.5%
diazepam inj 1
0.5%
diazepame 1
0.5%
diclo 1
0.5%
diclo inj 1
0.5%
diclo injectable 1
0.5%
diclofenac cp 1
0.5%
fer acide folique 1
0.5%
fil de suture 1
0.5%
flucazole gellule 1
0.5%
furo cp 1
0.5%
gant d'examen 1
0.5%
gant fil de siture 1
0.5%
gants 3
1.6%
gants d examen 1
0.5%
hpv, ASL 1
0.5%
hydoxyde 1
0.5%
hydrocortisone inj 1
0.5%
hydroxide 1
0.5%
iBUPROFENE 1
0.5%
ibuprofine 1
0.5%
mag 2 1
0.5%
maxillase 1
0.5%
mebendazole 1
0.5%
metro ovule 1
0.5%
metronidazole 1
0.5%
metronidazole injectale 1
0.5%
miconazole comp 1
0.5%
mitronidazole 1
0.5%
mucanazol pommade 1
0.5%
multivitamine 1
0.5%
multivitamine comp 1
0.5%
p0 1
0.5%
paracetamol 1
0.5%
paracetamol 500mg 1
0.5%
paracetamol comp 1
0.5%
paracetamole 500mg 1
0.5%
paracetamole cmprime 1
0.5%
perfalgan 2
1.1%
phloro 3
1.6%
phloro comprime 1
0.5%
phloroclucinol 1
0.5%
phloroglucinol 1
0.5%
phloroglucinol inj 2
1.1%
phloroglycinol 1
0.5%
pommade hec 1
0.5%
pot de prelevement 1
0.5%
rien 1
0.5%
seringue 3
1.6%
seringue 10 cc 1
0.5%
seringue 10cc 1
0.5%
sparadrap 2
1.1%
t 1
0.5%
vita c 1
0.5%
vitamine c 1
0.5%
xylocaïne 1
0.5%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.